The drug registration process in India involves rigorous evaluation by the Central Drugs Standard Control Organization (CDSCO) to ensure safety, efficacy, and quality before granting approval for marketing and distribution. The pharmaceutical industry in India is a dynamic and rapidly growing sector, offering significant opportunities for drug manufacturers worldwide. With a large population and increasing […]
Read More →India is becoming a popular choice for clinical trials due to several key advantages and benefits. The country offers a promising environment with a diverse patient population, making it ideal for gathering comprehensive data. With a population exceeding 1.3 billion, including a substantial patient pool across various demographics and medical conditions, India offers a vast […]
Read More →In recent years, there is a huge leap in the pharma industry towards rare disease research and orphan drug developments due to the great support from regulatory authorities such as faster approval timelines, supportive regulatory frameworks, financial incentives, and many more. Currently, large pharmaceutical companies like Novartis, GSK, Roche, and Pfizer are extremely active in […]
Read More →Pancreatitis, inflammation of the pancreas, is the leading cause of GI-related hospitalizations in the USA and many other countries, with a medical condition requiring emergent care. The yearly incidence of Acute Pancreatitis in the United States and western countries is approximately 70-80 new cases per 100,000 population and has increased over the last decade. In […]
Read More →A country with a large pool of patients, highly skilled Investigators, and supportive regulations to promote clinical research is a desired destination for any organization for clinical trials. India has a lot more to offer besides these advantages, enabling you to enjoy the timely completion of clinical trials and cost benefits. (India offers a 35 […]
Read More →With patients with ovarian cancer as the target trial population, clinical trial feasibility was performed. The clinical trial sites/investigators, who participated in this feasibility came mainly from India, Russia, the Philippines, Vietnam, Thailand, and South Korea. What are the causes of ovarian cancer? The causes of ovarian cancer are unclear but doctors have identified factors that […]
Read More →Worldwide, breast cancer is the most common invasive cancer in women. Along with lung cancer, breast cancer is the most commonly diagnosed cancer, with 2.09 million cases each in 2018, and Breast cancer affects 1 in 7 (14%) of women worldwide. What is breast cancer? Breast cancer is a cancer that develops from breast tissue. […]
Read More →